AU2022245235A1 - Methods and compositions for treating sleep apnea - Google Patents

Methods and compositions for treating sleep apnea Download PDF

Info

Publication number
AU2022245235A1
AU2022245235A1 AU2022245235A AU2022245235A AU2022245235A1 AU 2022245235 A1 AU2022245235 A1 AU 2022245235A1 AU 2022245235 A AU2022245235 A AU 2022245235A AU 2022245235 A AU2022245235 A AU 2022245235A AU 2022245235 A1 AU2022245235 A1 AU 2022245235A1
Authority
AU
Australia
Prior art keywords
pharmaceutically acceptable
acceptable salt
composition
nri
oxybutynin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022245235A
Other languages
English (en)
Inventor
Ronald FARKAS
Lawrence G. MILLER
Luigi TARANTO-MONTEMURRO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apnimed Inc
Original Assignee
Apnimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apnimed Inc filed Critical Apnimed Inc
Publication of AU2022245235A1 publication Critical patent/AU2022245235A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2022245235A 2021-03-24 2022-03-23 Methods and compositions for treating sleep apnea Pending AU2022245235A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163165342P 2021-03-24 2021-03-24
US63/165,342 2021-03-24
PCT/US2022/021462 WO2022204228A1 (en) 2021-03-24 2022-03-23 Methods and compositions for treating sleep apnea

Publications (1)

Publication Number Publication Date
AU2022245235A1 true AU2022245235A1 (en) 2023-10-12

Family

ID=81388916

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022245235A Pending AU2022245235A1 (en) 2021-03-24 2022-03-23 Methods and compositions for treating sleep apnea

Country Status (15)

Country Link
US (1) US20240173337A1 (https=)
EP (1) EP4313153A1 (https=)
JP (1) JP2024511091A (https=)
KR (1) KR20230159462A (https=)
CN (1) CN117062626A (https=)
AU (1) AU2022245235A1 (https=)
BR (1) BR112023019256A2 (https=)
CA (1) CA3212035A1 (https=)
CL (1) CL2023002824A1 (https=)
CO (1) CO2023012587A2 (https=)
CR (1) CR20230457A (https=)
GE (1) GEAP202416361A (https=)
IL (1) IL307186A (https=)
MX (1) MX2023011213A (https=)
WO (1) WO2022204228A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119789855A (zh) * 2022-09-02 2025-04-08 爱普宁公司(特拉华) 治疗睡眠呼吸暂停的方法和组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3746126B1 (en) * 2018-01-30 2024-07-31 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea or simple snoring
EP4635514A3 (en) * 2019-02-08 2025-12-24 The Brigham & Women's Hospital, Inc. Methods and compositions for treating sleep apnea
JP2023520455A (ja) * 2020-04-02 2023-05-17 アプニメッド，インコーポレイテッド（デラウェア） 睡眠時無呼吸を治療するための方法および組成物

Also Published As

Publication number Publication date
BR112023019256A2 (pt) 2023-10-17
CA3212035A1 (en) 2022-09-29
WO2022204228A1 (en) 2022-09-29
KR20230159462A (ko) 2023-11-21
JP2024511091A (ja) 2024-03-12
CR20230457A (es) 2024-02-19
CN117062626A (zh) 2023-11-14
CO2023012587A2 (es) 2023-10-19
MX2023011213A (es) 2023-10-02
EP4313153A1 (en) 2024-02-07
GEAP202416361A (en) 2024-04-25
US20240173337A1 (en) 2024-05-30
CL2023002824A1 (es) 2024-01-26
IL307186A (en) 2023-11-01

Similar Documents

Publication Publication Date Title
KR102682159B1 (ko) 수면 무호흡을 치료하기 위한 방법 및 조성물
JP2021516218A (ja) 睡眠時無呼吸を治療するための方法および組成物
US20240189328A1 (en) Combination of norepinephrine reuptake inhibitor and a cannabinoid for use in treating sleep apnea
US20240075035A1 (en) Methods and compositions for treating sleep apnea
US20240173337A1 (en) Methods and compositions for treating sleep apnea
US20240277719A1 (en) Norepinephrine reuptake inhibitors for treating sleep apnea
US20230135373A1 (en) Methods and compositions for treating sleep apnea
US20240358709A1 (en) Methods and compositions for treating sleep apnea
US20240139200A1 (en) Combination of reboxetine and a muscarinic receptor antagonist (mra) for use in treating sleep apnea
US20250009720A1 (en) Methods and compositions for treating sleep apnea
AU2023335927A1 (en) Methods and compositions for treating sleep apnea
CN117615764A (zh) 用于治疗睡眠呼吸暂停的去甲肾上腺素再摄取抑制剂